ARID3A and B-cell acute lymphoblastic leukemia: In B-ALL (B-cell Acute Lymphoblastic Leukemia), ARID3a is targeted by miR-125b, where ARID3a inhibits differentiation, increases proliferation and inhibits apoptosis [55].